Cita APA (7a ed.)
Feemster, A. A., Augustino, M., Duncan, R., Khandoobhai, A., & Rowcliffe, M. (2021). Use of failure modes and effects analysis to mitigate potential risks prior to implementation of an intravenous compounding technology. American Journal of Health-System Pharmacy, 78(14), 1323-1330.
Cita Chicago Style (17a ed.)
Feemster, Agnes Ann, Melissa Augustino, Rosemary Duncan, Anand Khandoobhai, y Meghan Rowcliffe. "Use of Failure Modes and Effects Analysis to Mitigate Potential Risks Prior to Implementation of an Intravenous Compounding Technology." American Journal of Health-System Pharmacy 78, no. 14 (2021): 1323-1330.
Cita MLA (9a ed.)
Feemster, Agnes Ann, et al. "Use of Failure Modes and Effects Analysis to Mitigate Potential Risks Prior to Implementation of an Intravenous Compounding Technology." American Journal of Health-System Pharmacy, vol. 78, no. 14, 2021, pp. 1323-1330.
Precaución: Estas citas no son 100% exactas.